Youcare Pharmaceutical Group Co., Ltd. (688658.SS)
CNY 18.35
(-2.18%)
CNY 18.35
(-2.18%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 184.79 Million CNY | -44.87% |
| 2022 | 335.18 Million CNY | -38.53% |
| 2021 | 545.31 Million CNY | 23.34% |
| 2020 | 442.13 Million CNY | 54.89% |
| 2019 | 285.45 Million CNY | 6.53% |
| 2018 | 267.94 Million CNY | 65.85% |
| 2017 | 161.56 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 91.17 Million CNY | 85.13% |
| 2024 Q2 | 49.24 Million CNY | -28.94% |
| 2024 Q1 | 69.3 Million CNY | 113.11% |
| 2023 FY | 184.79 Million CNY | -44.87% |
| 2023 Q4 | 32.52 Million CNY | 159.34% |
| 2023 Q1 | 85.26 Million CNY | 8848.64% |
| 2023 Q2 | 121.8 Million CNY | 42.85% |
| 2023 Q3 | -54.8 Million CNY | -144.99% |
| 2022 Q3 | 195.2 Million CNY | 154.07% |
| 2022 Q4 | 952.85 Thousand CNY | -99.51% |
| 2022 Q2 | 76.83 Million CNY | 21.06% |
| 2022 Q1 | 63.46 Million CNY | -63.05% |
| 2022 FY | 335.18 Million CNY | -38.53% |
| 2021 Q4 | 171.77 Million CNY | 6.95% |
| 2021 Q3 | 160.6 Million CNY | 12.51% |
| 2021 Q2 | 142.74 Million CNY | 103.37% |
| 2021 Q1 | 70.19 Million CNY | -62.69% |
| 2021 FY | 545.31 Million CNY | 23.34% |
| 2020 FY | 442.13 Million CNY | 54.89% |
| 2020 Q1 | 36.27 Million CNY | -65.12% |
| 2020 Q4 | 188.13 Million CNY | 54.53% |
| 2020 Q3 | 121.74 Million CNY | 26.85% |
| 2020 Q2 | 95.97 Million CNY | 164.6% |
| 2019 FY | 285.45 Million CNY | 6.53% |
| 2019 Q4 | 103.99 Million CNY | 176.2% |
| 2019 Q3 | 37.65 Million CNY | 0.0% |
| 2018 FY | 267.94 Million CNY | 65.85% |
| 2017 FY | 161.56 Million CNY | 0.0% |